Login
From:
Myasthenia Gravis News
(Uncensored)
subscribe
Immunovant positions IMVT-1402 as lead MG treatment candidate
https://myastheniagravisnews.com/news/immunovant-positions-imvt-1402-lead-mg-treatment-candidate/
links
backlinks
Tagged with:
batoclimab
immunovant
IImmunovant is prioritizing IMVT-1402 as its lead MG treatment candidate, with registrational clinical trials possible in the next year.
Roast topics
Find topics
Find it!
